Price Alert

Alcon Inc. (ALC)

NYSE: ALC · Real-Time Price · USD

77.39

2.28 (3.04%)

At close: Oct 03, 2025, 3:59 PM

77.65

0.34%

After-hours: Oct 03, 2025, 07:37 PM EDT

3.04% (1D)

Bid	75.55
Market Cap	38.26B
Revenue (ttm)	10.03B
Net Income (ttm)	1.07B
EPS (ttm)	2.16
PE Ratio (ttm)	35.83
Forward PE	21.34
Analyst	Buy
Dividends	$0.6

Ask	77.65
Volume	2,259,494
Avg. Volume (20D)	2,181,827.7
Open	75.83
Previous Close	75.11
Day's Range	75.60 - 77.50
52-Week Range	73.22 - 99.20
Beta	0.69
Ex-Dividend Date	May 13, 2025

About ALC

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ALC

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ALC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Alcon Inc. is scheduled to release its earnings on Nov 11, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

-2.3%

Alcon shares are trading lower after Stifel cut it... Unlock content with Pro Subscription

1 month ago

-10.08%

Alcon shares are trading lower after the company cut its FY25 sales guidance.

News

2 days ago · businesswire.com

Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical's Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or...

5 days ago · businesswire.com

Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon's Acquisition of STAAR

GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), th...

6 days ago · seekingalpha.com

Alcon: Seeing Is Believing As Buyout Of STAAR Surgical Hangs In Balance

Alcon Inc. gets upgraded to a Buy again after my prior hold rating. Upside could come from macro-level clinical demand in the eyecare niche, but also a diverse and growing product portfolio in both th...

1 week ago · businesswire.com

Algoma Central Corporation Celebrates 100th Vessel Milestone

ST. CATHARINES, Ontario--(BUSINESS WIRE)-- #yourmarinecarrierofchoice--Algoma Central Corporation (“Algoma” or “the Company”) (TSX:ALC), today took delivery of the Algoma Legacy, the first of three ne...

1 week ago · businesswire.com

STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, toda...

1 week ago · businesswire.com

STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received

1 week ago · businesswire.com

Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company's Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon

HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company...